Related references
Note: Only part of the references are listed.IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma
Rob A. Cairns et al.
BLOOD (2012)
TET2 and DNMT3A Mutations in Human T-Cell Lymphoma
Lucile Couronne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies
Zhe Li et al.
BLOOD (2011)
TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis
Cyril Quivoron et al.
CANCER CELL (2011)
Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
Kelly Moran-Crusio et al.
CANCER CELL (2011)
TET Family Proteins and Their Role in Stem Cell Differentiation and Transformation
Luisa Cimmino et al.
CELL STEM CELL (2011)
Inactivating mutations of acetyltransferase genes in B-cell lymphoma
Laura Pasqualucci et al.
NATURE (2011)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D. Morin et al.
NATURE (2011)
Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine
Shinsuke Ito et al.
SCIENCE (2011)
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
Javeed Iqbal et al.
BLOOD (2010)
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Maria E. Figueroa et al.
CANCER CELL (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
Omar Abdel-Wahab et al.
BLOOD (2009)
Mutation in TET2 in Myeloid Cancers
Francois Delhommeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta Tahiliani et al.
SCIENCE (2009)
Peripheral T-cell Lymphoma With Follicular T-cell Markers
Socorro Maria Rodriguez-Pinilla et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials
Nathalie Mourad et al.
BLOOD (2008)
International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes
Julie M. Vose et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Pathobiology and Molecular Profiling of Peripheral T-Cell Lymphomas
L. de Leval et al.
Hematology-American Society of Hematology Education Program (2008)
Gene expression analysis of Angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation
Pier Paolo Piccaluga et al.
CANCER RESEARCH (2007)
The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells
Laurence de Leval et al.
BLOOD (2007)
Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL) - A new diagnostic marker providing evidence that AITL derives from follicular helper T cells
J Dupuis et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study
A Gallamini et al.
BLOOD (2004)
Share Paper
